Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 14, 2006 08:30 ET | Source: Manhattan Pharmaceuticals, Inc.

Manhattan Pharmaceuticals Reports Results for Six Months Ended June 30, 2006 and Reduced Loss for the Three Months Ended March 3, 2006

NEW YORK, Aug. 14, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced financial results for the six months ended June 30, 2006. Net loss for the period was approximately...
July 19, 2006 08:29 ET | Source: Manhattan Pharmaceuticals, Inc.

Manhattan Pharmaceuticals to Present at 2nd Annual Obesity Drug Development Summit

NEW YORK, July 19, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Alan G. Harris, MD, PhD, chief medical officer, will present a scientific overview of oral...
July 10, 2006 10:21 ET | Source: Manhattan Pharmaceuticals, Inc.

Manhattan Pharmaceuticals Names Michael G. McGuinness as Chief Financial Officer

NEW YORK, July 10, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Michael G. McGuinness joined the company as Chief Financial Officer, effective today. Mr....
July 05, 2006 08:29 ET | Source: Manhattan Pharmaceuticals, Inc.

Manhattan Pharmaceuticals to Present at CE Unterberg Towbin Emerging Growth Conference

NEW YORK, July 5, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Douglas Abel, president and chief executive officer of Manhattan Pharmaceuticals, Inc. will be...
June 07, 2006 10:09 ET | Source: Manhattan Pharmaceuticals, Inc.

Manhattan Pharmaceuticals to Ring Opening Bell At American Stock Exchange

NEW YORK, June 7, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Douglas Abel, president and chief executive officer, will ring the opening bell at the American...
June 06, 2006 08:29 ET | Source: Manhattan Pharmaceuticals, Inc.

Manhattan Pharmaceuticals to Present at Pacific Growth Equities Life Sciences Growth Conference

NEW YORK, June 6, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Douglas Abel, president and chief executive officer of Manhattan Pharmaceuticals, Inc. will be...
May 24, 2006 08:29 ET | Source: Manhattan Pharmaceuticals, Inc.

Manhattan Pharmaceuticals to Present at Friedman Billings Ramsey 2006 Growth Investor Conference

NEW YORK, May 24, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Douglas Abel, president and chief executive officer of Manhattan Pharmaceuticals, Inc. will be...
May 10, 2006 10:22 ET | Source: Manhattan Pharmaceuticals, Inc.

Manhattan Pharmaceuticals to Present at Rodman & Renshaw 3rd Annual Global Healthcare Conference, May 15-16, Monaco

NEW YORK, May 10, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Douglas Abel, president and chief executive officer of Manhattan Pharmaceuticals, Inc. will be...
May 08, 2006 11:21 ET | Source: Manhattan Pharmaceuticals, Inc.

Manhattan Pharmaceuticals Invited to Participate in Three Scientific Meetings On Obesity and Related Disorders

NEW YORK, May 8, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) announced today it has accepted invitations to participate in three upcoming scientific meetings focused on obesity and...
April 28, 2006 16:10 ET | Source: Manhattan Pharmaceuticals, Inc.

Manhattan Pharmaceuticals Reports Update on Clinical Development Programs

NEW YORK, April 28, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) announced the following update regarding the development status of oral Oleoyl-estrone for obesity and topical PTH...